Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Hospital-Based Smoking Cessation
NCT00261170Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Jul 2003
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nicotine dependence comparing Bupropion Arm with Placebo Arm (2 arms). Primary endpoint: Smoking status at 6 months after enrollment. Started Jul 2003; status: completed.
02
Drugs
bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00261170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261170.